Global Hemodialysis & Peritoneal Dialysis
Global Hemodialysis & Peritoneal Dialysis

Hemodialysis & Peritoneal Dialysis Comprehensive Study by Type (Hemodialysis (Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis), Peritoneal Dialysis (Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD))), Product Type (Device (Machine, Dialyzer, Water Treatment System, Others), Consumables (Bloodline, Concentrates, Catheters, Others), Services), End-Users (In-center Dialysis, Hospitals, Independent Dialysis Centers, Home Dialysis, Peritoneal Dialysis), Modality (Conventional, Daily, Nocturnal) Players and Region - Global Market Outlook to 2026

Hemodialysis & Peritoneal Dialysis Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Mar 2021 Edition 237 Pages 200 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Hemodialysis & Peritoneal Dialysis Market Scope?
Dialysis is a technique for removing waste products such as urea and creatinine from the blood, caused by inadequate kidney function and usually required in people with chronic kidney failure. This procedure is used to treat kidney disease and is divided into two types: hemodialysis and peritoneal dialysis. In hemodialysis, blood is pumped from blood vessels and cleaned with the aid of a dialyzer, and then returned to the body via vascular access. In peritoneal dialysis, the principle of the procedure remains the same, but the inner stomach lining known as the peritoneum is used as a filter to cleanse the blood. Market growth is mainly driven by factors such as the increasing number of ESRD patients, the increasing prevalence of diabetes and high blood pressure (major causes of kidney failure), and the preference for dialysis treatments over kidney transplants due to a lack of donors. In addition, the increase in the number of dialysis centers around the world, organ donor shortages and transplant risks, technological advances, and initiatives by leading players to introduce advanced products and services provide growth opportunities for the Hemodialysis and Peritoneal Dialysis market. The other factors that contribute to the decreased preference for kidney transplants are a patient aversion to organ donation, financial constraints, lack of adequate surgical facilities, risks of surgery such as organ rejection, and complications from side effects of immunosuppressive drugs. These challenges associated with kidney transplants have resulted in a low preference for these procedures, which in turn has led to an increase in the number of patients who have opted for dialysis.

The Hemodialysis & Peritoneal Dialysis market study is being classified by Type (Hemodialysis [Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis] and Peritoneal Dialysis [Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)]) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Players from European will contribute to the maximum growth of Global Hemodialysis & Peritoneal Dialysis market throughout the predicted period.

Fresenius Medical Care AG & Co. KGAA (Germany), DaVita Healthcare Partners Inc. (United States), Becton, Dickinson, and Company (United States), Medtronic plc (Ireland), Baxter International Inc. (United States), B. Braun Melsungen AG (Germany), Diaverum Deutschland Gmbh (Germany), Nipro Corporation (Japan), Asahi Kasei Medical Co., Ltd. (Japan), Nikkiso Co., Ltd. (Japan), 3M (United States), Toray Industries, Inc. (Japan), Davita Healthcare Partners Inc. (United States), Isopure Corp. (United States) and Mar Cor (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Atlantic Biomedical (India), Dialife SA (Switzerland), Allmed Medical Care Holdings Limited (United Kingdom), Rockwell Medical Inc. (United States) and JMS Co. Ltd. (Japan).

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Hemodialysis & Peritoneal Dialysis market by Type, Application and Region.

On the basis of geography, the market of Hemodialysis & Peritoneal Dialysis has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Market Influencers and their development strategies
In 2019, Fresenius Medical Care had acquired NxStage Medical, Inc., which is a US-based home dialysis leader. With this acquisition, the company had aimed to expand its presence in the dialysis market
In 2018, B. Braun Melsungen AG had opened a production site for dialyzers in Saxony (Germany) that was thereby aimed at increasing access to an advanced dialysis product in the country


Influencing Market Trend
  • Growing Prevalence of Diabetes & Hypertension Which Is a Major Causes of Kidney Failure
  • The Growing Incidence of ESRD
  • The Rising Acceptance of Home Hemodialysis and Peritoneal Dialysis

Market Drivers
  • The Increasing Number of Dialysis Centers across the Globe
  • A Rise in New Product Launches
  • The Availability of Healthcare Professionals in Dialysis Centers
  • Increasing Per Capita Income
  • The Increasing Geriatric Population

Opportunities
  • Improving Healthcare Infrastructure
  • Supportive Government Activities in the Emerging Countries

Restraints
  • Reimbursement Concerns in Emerging Market
  • Rise in Complications Related To Dialysis Treatment

Challenges
  • Lack of Sufficient Surgical Facilities


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Hemodialysis & Peritoneal Dialysis, Venture Capitalists and Private Equity Firms and End-Use Industry

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.
Report Objectives / Segmentation Covered
By Type
  • Hemodialysis [Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis]
  • Peritoneal Dialysis [Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)]
By Product Type
  • Device [Machine, Dialyzer, Water Treatment System, Others]
  • Consumables [Bloodline, Concentrates, Catheters, Others]
  • Services

By End-Users
  • In-center Dialysis
  • Hospitals
  • Independent Dialysis Centers
  • Home Dialysis
  • Peritoneal Dialysis

By Modality
  • Conventional
  • Daily
  • Nocturnal

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Increasing Number of Dialysis Centers across the Globe
      • 3.2.2. A Rise in New Product Launches
      • 3.2.3. The Availability of Healthcare Professionals in Dialysis Centers
      • 3.2.4. Increasing Per Capita Income
      • 3.2.5. The Increasing Geriatric Population
    • 3.3. Market Challenges
      • 3.3.1. Lack of Sufficient Surgical Facilities
    • 3.4. Market Trends
      • 3.4.1. Growing Prevalence of Diabetes & Hypertension Which Is a Major Causes of Kidney Failure
      • 3.4.2. The Growing Incidence of ESRD
      • 3.4.3. The Rising Acceptance of Home Hemodialysis and Peritoneal Dialysis
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Hemodialysis & Peritoneal Dialysis, by Type, Product Type, End-Users, Modality and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Hemodialysis & Peritoneal Dialysis (Value)
      • 5.2.1. Global Hemodialysis & Peritoneal Dialysis by: Type (Value)
        • 5.2.1.1. Hemodialysis [Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis]
        • 5.2.1.2. Peritoneal Dialysis [Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)]
      • 5.2.2. Global Hemodialysis & Peritoneal Dialysis by: Type (Value)
        • 5.2.2.1. Hemodialysis [Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis]
        • 5.2.2.2. Peritoneal Dialysis [Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)]
      • 5.2.3. Global Hemodialysis & Peritoneal Dialysis by: Product Type (Value)
        • 5.2.3.1. Device [Machine, Dialyzer, Water Treatment System, Others]
        • 5.2.3.2. Consumables [Bloodline, Concentrates, Catheters, Others]
        • 5.2.3.3. Services
      • 5.2.4. Global Hemodialysis & Peritoneal Dialysis by: End-Users (Value)
        • 5.2.4.1. In-center Dialysis
        • 5.2.4.2. Hospitals
        • 5.2.4.3. Independent Dialysis Centers
        • 5.2.4.4. Home Dialysis
        • 5.2.4.5. Peritoneal Dialysis
      • 5.2.5. Global Hemodialysis & Peritoneal Dialysis by: Modality (Value)
        • 5.2.5.1. Conventional
        • 5.2.5.2. Daily
        • 5.2.5.3. Nocturnal
      • 5.2.6. Global Hemodialysis & Peritoneal Dialysis Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Hemodialysis & Peritoneal Dialysis (Price)
      • 5.3.1. Global Hemodialysis & Peritoneal Dialysis by: Type (Price)
  • 6. Hemodialysis & Peritoneal Dialysis: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Fresenius Medical Care AG & Co. KGAA (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. DaVita Healthcare Partners Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Becton, Dickinson, and Company (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Medtronic plc (Ireland)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Baxter International Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. B. Braun Melsungen AG (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Diaverum Deutschland Gmbh (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Nipro Corporation (Japan)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Asahi Kasei Medical Co., Ltd. (Japan)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Nikkiso Co., Ltd. (Japan)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. 3M (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Toray Industries, Inc. (Japan)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
      • 6.4.13. Davita Healthcare Partners Inc. (United States)
        • 6.4.13.1. Business Overview
        • 6.4.13.2. Products/Services Offerings
        • 6.4.13.3. Financial Analysis
        • 6.4.13.4. SWOT Analysis
      • 6.4.14. Isopure Corp. (United States)
        • 6.4.14.1. Business Overview
        • 6.4.14.2. Products/Services Offerings
        • 6.4.14.3. Financial Analysis
        • 6.4.14.4. SWOT Analysis
      • 6.4.15. Mar Cor (United States)
        • 6.4.15.1. Business Overview
        • 6.4.15.2. Products/Services Offerings
        • 6.4.15.3. Financial Analysis
        • 6.4.15.4. SWOT Analysis
  • 7. Global Hemodialysis & Peritoneal Dialysis Sale, by Type, Product Type, End-Users, Modality and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Hemodialysis & Peritoneal Dialysis (Value)
      • 7.2.1. Global Hemodialysis & Peritoneal Dialysis by: Type (Value)
        • 7.2.1.1. Hemodialysis [Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis]
        • 7.2.1.2. Peritoneal Dialysis [Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)]
      • 7.2.2. Global Hemodialysis & Peritoneal Dialysis by: Type (Value)
        • 7.2.2.1. Hemodialysis [Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis]
        • 7.2.2.2. Peritoneal Dialysis [Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)]
      • 7.2.3. Global Hemodialysis & Peritoneal Dialysis by: Product Type (Value)
        • 7.2.3.1. Device [Machine, Dialyzer, Water Treatment System, Others]
        • 7.2.3.2. Consumables [Bloodline, Concentrates, Catheters, Others]
        • 7.2.3.3. Services
      • 7.2.4. Global Hemodialysis & Peritoneal Dialysis by: End-Users (Value)
        • 7.2.4.1. In-center Dialysis
        • 7.2.4.2. Hospitals
        • 7.2.4.3. Independent Dialysis Centers
        • 7.2.4.4. Home Dialysis
        • 7.2.4.5. Peritoneal Dialysis
      • 7.2.5. Global Hemodialysis & Peritoneal Dialysis by: Modality (Value)
        • 7.2.5.1. Conventional
        • 7.2.5.2. Daily
        • 7.2.5.3. Nocturnal
      • 7.2.6. Global Hemodialysis & Peritoneal Dialysis Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Hemodialysis & Peritoneal Dialysis (Price)
      • 7.3.1. Global Hemodialysis & Peritoneal Dialysis by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Hemodialysis & Peritoneal Dialysis: by Type(USD Million)
  • Table 2. Hemodialysis & Peritoneal Dialysis Hemodialysis [Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis] , by Region USD Million (2015-2020)
  • Table 3. Hemodialysis & Peritoneal Dialysis Peritoneal Dialysis [Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)] , by Region USD Million (2015-2020)
  • Table 4. Hemodialysis & Peritoneal Dialysis: by Type(USD Million)
  • Table 5. Hemodialysis & Peritoneal Dialysis Hemodialysis [Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis] , by Region USD Million (2015-2020)
  • Table 6. Hemodialysis & Peritoneal Dialysis Peritoneal Dialysis [Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)] , by Region USD Million (2015-2020)
  • Table 7. Hemodialysis & Peritoneal Dialysis: by Product Type(USD Million)
  • Table 8. Hemodialysis & Peritoneal Dialysis Device [Machine, Dialyzer, Water Treatment System, Others] , by Region USD Million (2015-2020)
  • Table 9. Hemodialysis & Peritoneal Dialysis Consumables [Bloodline, Concentrates, Catheters, Others] , by Region USD Million (2015-2020)
  • Table 10. Hemodialysis & Peritoneal Dialysis Services , by Region USD Million (2015-2020)
  • Table 11. Hemodialysis & Peritoneal Dialysis: by End-Users(USD Million)
  • Table 12. Hemodialysis & Peritoneal Dialysis In-center Dialysis , by Region USD Million (2015-2020)
  • Table 13. Hemodialysis & Peritoneal Dialysis Hospitals , by Region USD Million (2015-2020)
  • Table 14. Hemodialysis & Peritoneal Dialysis Independent Dialysis Centers , by Region USD Million (2015-2020)
  • Table 15. Hemodialysis & Peritoneal Dialysis Home Dialysis , by Region USD Million (2015-2020)
  • Table 16. Hemodialysis & Peritoneal Dialysis Peritoneal Dialysis , by Region USD Million (2015-2020)
  • Table 17. Hemodialysis & Peritoneal Dialysis: by Modality(USD Million)
  • Table 18. Hemodialysis & Peritoneal Dialysis Conventional , by Region USD Million (2015-2020)
  • Table 19. Hemodialysis & Peritoneal Dialysis Daily , by Region USD Million (2015-2020)
  • Table 20. Hemodialysis & Peritoneal Dialysis Nocturnal , by Region USD Million (2015-2020)
  • Table 21. South America Hemodialysis & Peritoneal Dialysis, by Country USD Million (2015-2020)
  • Table 22. South America Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 23. South America Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 24. South America Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 25. South America Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 26. Brazil Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 27. Brazil Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 28. Brazil Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 29. Brazil Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 30. Argentina Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 31. Argentina Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 32. Argentina Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 33. Argentina Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 34. Rest of South America Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 35. Rest of South America Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 36. Rest of South America Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 37. Rest of South America Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 38. Asia Pacific Hemodialysis & Peritoneal Dialysis, by Country USD Million (2015-2020)
  • Table 39. Asia Pacific Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 40. Asia Pacific Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 41. Asia Pacific Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 42. Asia Pacific Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 43. China Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 44. China Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 45. China Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 46. China Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 47. Japan Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 48. Japan Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 49. Japan Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 50. Japan Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 51. India Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 52. India Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 53. India Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 54. India Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 55. South Korea Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 56. South Korea Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 57. South Korea Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 58. South Korea Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 59. Taiwan Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 60. Taiwan Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 61. Taiwan Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 62. Taiwan Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 63. Australia Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 64. Australia Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 65. Australia Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 66. Australia Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 67. Rest of Asia-Pacific Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 68. Rest of Asia-Pacific Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 69. Rest of Asia-Pacific Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 70. Rest of Asia-Pacific Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 71. Europe Hemodialysis & Peritoneal Dialysis, by Country USD Million (2015-2020)
  • Table 72. Europe Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 73. Europe Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 74. Europe Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 75. Europe Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 76. Germany Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 77. Germany Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 78. Germany Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 79. Germany Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 80. France Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 81. France Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 82. France Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 83. France Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 84. Italy Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 85. Italy Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 86. Italy Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 87. Italy Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 88. United Kingdom Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 89. United Kingdom Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 90. United Kingdom Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 91. United Kingdom Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 92. Netherlands Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 93. Netherlands Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 94. Netherlands Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 95. Netherlands Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 96. Rest of Europe Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 97. Rest of Europe Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 98. Rest of Europe Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 99. Rest of Europe Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 100. MEA Hemodialysis & Peritoneal Dialysis, by Country USD Million (2015-2020)
  • Table 101. MEA Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 102. MEA Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 103. MEA Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 104. MEA Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 105. Middle East Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 106. Middle East Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 107. Middle East Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 108. Middle East Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 109. Africa Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 110. Africa Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 111. Africa Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 112. Africa Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 113. North America Hemodialysis & Peritoneal Dialysis, by Country USD Million (2015-2020)
  • Table 114. North America Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 115. North America Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 116. North America Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 117. North America Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 118. United States Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 119. United States Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 120. United States Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 121. United States Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 122. Canada Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 123. Canada Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 124. Canada Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 125. Canada Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 126. Mexico Hemodialysis & Peritoneal Dialysis, by Type USD Million (2015-2020)
  • Table 127. Mexico Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2015-2020)
  • Table 128. Mexico Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2015-2020)
  • Table 129. Mexico Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2015-2020)
  • Table 130. Hemodialysis & Peritoneal Dialysis: by Type(USD/Units)
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Hemodialysis & Peritoneal Dialysis: by Type(USD Million)
  • Table 147. Hemodialysis & Peritoneal Dialysis Hemodialysis [Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis] , by Region USD Million (2021-2026)
  • Table 148. Hemodialysis & Peritoneal Dialysis Peritoneal Dialysis [Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)] , by Region USD Million (2021-2026)
  • Table 149. Hemodialysis & Peritoneal Dialysis: by Type(USD Million)
  • Table 150. Hemodialysis & Peritoneal Dialysis Hemodialysis [Conventional Hemodialysis, Short Daily Hemodialysis, Nocturnal Hemodialysis] , by Region USD Million (2021-2026)
  • Table 151. Hemodialysis & Peritoneal Dialysis Peritoneal Dialysis [Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)] , by Region USD Million (2021-2026)
  • Table 152. Hemodialysis & Peritoneal Dialysis: by Product Type(USD Million)
  • Table 153. Hemodialysis & Peritoneal Dialysis Device [Machine, Dialyzer, Water Treatment System, Others] , by Region USD Million (2021-2026)
  • Table 154. Hemodialysis & Peritoneal Dialysis Consumables [Bloodline, Concentrates, Catheters, Others] , by Region USD Million (2021-2026)
  • Table 155. Hemodialysis & Peritoneal Dialysis Services , by Region USD Million (2021-2026)
  • Table 156. Hemodialysis & Peritoneal Dialysis: by End-Users(USD Million)
  • Table 157. Hemodialysis & Peritoneal Dialysis In-center Dialysis , by Region USD Million (2021-2026)
  • Table 158. Hemodialysis & Peritoneal Dialysis Hospitals , by Region USD Million (2021-2026)
  • Table 159. Hemodialysis & Peritoneal Dialysis Independent Dialysis Centers , by Region USD Million (2021-2026)
  • Table 160. Hemodialysis & Peritoneal Dialysis Home Dialysis , by Region USD Million (2021-2026)
  • Table 161. Hemodialysis & Peritoneal Dialysis Peritoneal Dialysis , by Region USD Million (2021-2026)
  • Table 162. Hemodialysis & Peritoneal Dialysis: by Modality(USD Million)
  • Table 163. Hemodialysis & Peritoneal Dialysis Conventional , by Region USD Million (2021-2026)
  • Table 164. Hemodialysis & Peritoneal Dialysis Daily , by Region USD Million (2021-2026)
  • Table 165. Hemodialysis & Peritoneal Dialysis Nocturnal , by Region USD Million (2021-2026)
  • Table 166. South America Hemodialysis & Peritoneal Dialysis, by Country USD Million (2021-2026)
  • Table 167. South America Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 168. South America Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 169. South America Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 170. South America Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 171. Brazil Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 172. Brazil Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 173. Brazil Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 174. Brazil Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 175. Argentina Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 176. Argentina Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 177. Argentina Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 178. Argentina Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 179. Rest of South America Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 180. Rest of South America Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 181. Rest of South America Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 182. Rest of South America Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 183. Asia Pacific Hemodialysis & Peritoneal Dialysis, by Country USD Million (2021-2026)
  • Table 184. Asia Pacific Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 185. Asia Pacific Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 186. Asia Pacific Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 187. Asia Pacific Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 188. China Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 189. China Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 190. China Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 191. China Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 192. Japan Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 193. Japan Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 194. Japan Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 195. Japan Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 196. India Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 197. India Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 198. India Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 199. India Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 200. South Korea Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 201. South Korea Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 202. South Korea Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 203. South Korea Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 204. Taiwan Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 205. Taiwan Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 206. Taiwan Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 207. Taiwan Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 208. Australia Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 209. Australia Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 210. Australia Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 211. Australia Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 212. Rest of Asia-Pacific Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 213. Rest of Asia-Pacific Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 214. Rest of Asia-Pacific Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 215. Rest of Asia-Pacific Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 216. Europe Hemodialysis & Peritoneal Dialysis, by Country USD Million (2021-2026)
  • Table 217. Europe Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 218. Europe Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 219. Europe Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 220. Europe Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 221. Germany Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 222. Germany Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 223. Germany Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 224. Germany Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 225. France Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 226. France Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 227. France Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 228. France Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 229. Italy Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 230. Italy Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 231. Italy Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 232. Italy Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 233. United Kingdom Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 234. United Kingdom Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 235. United Kingdom Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 236. United Kingdom Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 237. Netherlands Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 238. Netherlands Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 239. Netherlands Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 240. Netherlands Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 241. Rest of Europe Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 242. Rest of Europe Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 243. Rest of Europe Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 244. Rest of Europe Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 245. MEA Hemodialysis & Peritoneal Dialysis, by Country USD Million (2021-2026)
  • Table 246. MEA Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 247. MEA Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 248. MEA Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 249. MEA Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 250. Middle East Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 251. Middle East Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 252. Middle East Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 253. Middle East Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 254. Africa Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 255. Africa Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 256. Africa Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 257. Africa Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 258. North America Hemodialysis & Peritoneal Dialysis, by Country USD Million (2021-2026)
  • Table 259. North America Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 260. North America Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 261. North America Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 262. North America Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 263. United States Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 264. United States Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 265. United States Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 266. United States Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 267. Canada Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 268. Canada Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 269. Canada Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 270. Canada Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 271. Mexico Hemodialysis & Peritoneal Dialysis, by Type USD Million (2021-2026)
  • Table 272. Mexico Hemodialysis & Peritoneal Dialysis, by Product Type USD Million (2021-2026)
  • Table 273. Mexico Hemodialysis & Peritoneal Dialysis, by End-Users USD Million (2021-2026)
  • Table 274. Mexico Hemodialysis & Peritoneal Dialysis, by Modality USD Million (2021-2026)
  • Table 275. Hemodialysis & Peritoneal Dialysis: by Type(USD/Units)
  • Table 276. Research Programs/Design for This Report
  • Table 277. Key Data Information from Secondary Sources
  • Table 278. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Hemodialysis & Peritoneal Dialysis: by Type USD Million (2015-2020)
  • Figure 5. Global Hemodialysis & Peritoneal Dialysis: by Type USD Million (2015-2020)
  • Figure 6. Global Hemodialysis & Peritoneal Dialysis: by Product Type USD Million (2015-2020)
  • Figure 7. Global Hemodialysis & Peritoneal Dialysis: by End-Users USD Million (2015-2020)
  • Figure 8. Global Hemodialysis & Peritoneal Dialysis: by Modality USD Million (2015-2020)
  • Figure 9. South America Hemodialysis & Peritoneal Dialysis Share (%), by Country
  • Figure 10. Asia Pacific Hemodialysis & Peritoneal Dialysis Share (%), by Country
  • Figure 11. Europe Hemodialysis & Peritoneal Dialysis Share (%), by Country
  • Figure 12. MEA Hemodialysis & Peritoneal Dialysis Share (%), by Country
  • Figure 13. North America Hemodialysis & Peritoneal Dialysis Share (%), by Country
  • Figure 14. Global Hemodialysis & Peritoneal Dialysis: by Type USD/Units (2015-2020)
  • Figure 15. Global Hemodialysis & Peritoneal Dialysis share by Players 2020 (%)
  • Figure 16. Global Hemodialysis & Peritoneal Dialysis share by Players (Top 3) 2020(%)
  • Figure 17. Global Hemodialysis & Peritoneal Dialysis share by Players (Top 5) 2020(%)
  • Figure 18. BCG Matrix for key Companies
  • Figure 19. Fresenius Medical Care AG & Co. KGAA (Germany) Revenue, Net Income and Gross profit
  • Figure 20. Fresenius Medical Care AG & Co. KGAA (Germany) Revenue: by Geography 2020
  • Figure 21. DaVita Healthcare Partners Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 22. DaVita Healthcare Partners Inc. (United States) Revenue: by Geography 2020
  • Figure 23. Becton, Dickinson, and Company (United States) Revenue, Net Income and Gross profit
  • Figure 24. Becton, Dickinson, and Company (United States) Revenue: by Geography 2020
  • Figure 25. Medtronic plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 26. Medtronic plc (Ireland) Revenue: by Geography 2020
  • Figure 27. Baxter International Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 28. Baxter International Inc. (United States) Revenue: by Geography 2020
  • Figure 29. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 30. B. Braun Melsungen AG (Germany) Revenue: by Geography 2020
  • Figure 31. Diaverum Deutschland Gmbh (Germany) Revenue, Net Income and Gross profit
  • Figure 32. Diaverum Deutschland Gmbh (Germany) Revenue: by Geography 2020
  • Figure 33. Nipro Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 34. Nipro Corporation (Japan) Revenue: by Geography 2020
  • Figure 35. Asahi Kasei Medical Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 36. Asahi Kasei Medical Co., Ltd. (Japan) Revenue: by Geography 2020
  • Figure 37. Nikkiso Co., Ltd. (Japan) Revenue, Net Income and Gross profit
  • Figure 38. Nikkiso Co., Ltd. (Japan) Revenue: by Geography 2020
  • Figure 39. 3M (United States) Revenue, Net Income and Gross profit
  • Figure 40. 3M (United States) Revenue: by Geography 2020
  • Figure 41. Toray Industries, Inc. (Japan) Revenue, Net Income and Gross profit
  • Figure 42. Toray Industries, Inc. (Japan) Revenue: by Geography 2020
  • Figure 43. Davita Healthcare Partners Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 44. Davita Healthcare Partners Inc. (United States) Revenue: by Geography 2020
  • Figure 45. Isopure Corp. (United States) Revenue, Net Income and Gross profit
  • Figure 46. Isopure Corp. (United States) Revenue: by Geography 2020
  • Figure 47. Mar Cor (United States) Revenue, Net Income and Gross profit
  • Figure 48. Mar Cor (United States) Revenue: by Geography 2020
  • Figure 49. Global Hemodialysis & Peritoneal Dialysis: by Type USD Million (2021-2026)
  • Figure 50. Global Hemodialysis & Peritoneal Dialysis: by Type USD Million (2021-2026)
  • Figure 51. Global Hemodialysis & Peritoneal Dialysis: by Product Type USD Million (2021-2026)
  • Figure 52. Global Hemodialysis & Peritoneal Dialysis: by End-Users USD Million (2021-2026)
  • Figure 53. Global Hemodialysis & Peritoneal Dialysis: by Modality USD Million (2021-2026)
  • Figure 54. South America Hemodialysis & Peritoneal Dialysis Share (%), by Country
  • Figure 55. Asia Pacific Hemodialysis & Peritoneal Dialysis Share (%), by Country
  • Figure 56. Europe Hemodialysis & Peritoneal Dialysis Share (%), by Country
  • Figure 57. MEA Hemodialysis & Peritoneal Dialysis Share (%), by Country
  • Figure 58. North America Hemodialysis & Peritoneal Dialysis Share (%), by Country
  • Figure 59. Global Hemodialysis & Peritoneal Dialysis: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Fresenius Medical Care AG & Co. KGAA (Germany)
  • DaVita Healthcare Partners Inc. (United States)
  • Becton, Dickinson, and Company (United States)
  • Medtronic plc (Ireland)
  • Baxter International Inc. (United States)
  • B. Braun Melsungen AG (Germany)
  • Diaverum Deutschland Gmbh (Germany)
  • Nipro Corporation (Japan)
  • Asahi Kasei Medical Co., Ltd. (Japan)
  • Nikkiso Co., Ltd. (Japan)
  • 3M (United States)
  • Toray Industries, Inc. (Japan)
  • Davita Healthcare Partners Inc. (United States)
  • Isopure Corp. (United States)
  • Mar Cor (United States)
Additional players considered in the study are as follows:
Atlantic Biomedical (India) , Dialife SA (Switzerland) , Allmed Medical Care Holdings Limited (United Kingdom) , Rockwell Medical Inc. (United States) , JMS Co. Ltd. (Japan)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation